Log in to search using one of your social media accounts:

This page shows you the latest news items in this category.

Celgene 1st quarter sales miss; expects psoriasis drug rebound
(Reuters) - Celgene Corp on Thursday reported lower-than-expected first-quarter revenue with Otezla sales well short of Wall Street estimates, but the U.S. biotechnology company promised the psoriasis drug was poised to rebound. (Source: Reuters: Health)
Source: Reuters: Health - April 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Can I get a tattoo if I have psoriasis?
Tattoos are common in the United States, but they can pose significant health risks to someone with psoriasis. Find out more in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 27, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

CME Outfitters Presents Findings at National Dermatology Meeting...
CME Outfitters presented poster at Maui Derm for Dermatologists 2017 Meeting showing improved educational outcomes in psoriasis via medical simulation.(PRWeb April 27, 2017)Read the full story at http://www.prweb.com/releases/2017/04/prweb14287919.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 27, 2017 Category: Pharmaceuticals Source Type: news

NICE recommends Ixekizumab (Taltz) to treat severe plaque psoriasis
Eli Lilly and Company has announced that UK NICE has recommended the usage of Ixekizumab (Taltz) as an option to treat adult patients suffering from severe plaque psoriasis who have responded inadequately to standard systemic therapies. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 26, 2017 Category: Pharmaceuticals Source Type: news

Cost controls help offset lower Amgen first-quarter drug sales
(Reuters) - Amgen Inc on Wednesday reported higher-than-expected first-quarter profit as cost controls helped offset a sharp drop in sales of Enbrel, its blockbuster rheumatoid arthritis and psoriasis drug. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Disease-associated genes routinely missed in some genetic studies
New research reveals two new ways to identify genes that routinely are missed in studies using a common gene-sequencing method. Many of these missed genes are associated with leukemia, psoriasis, heart failure, and other diseases. As part of their new research, the team of scientists have packaged their new methods into open-source software for other researchers to use.   (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 24, 2017 Category: Science Source Type: news

Valeant Pharmaceuticals lists price of plaque psoriasis drug at $3,500 per month
Valeant Pharmaceuticals International has decided to set the price of its biologic psoriasis treatment, known as Siliq (brodalumab) injection, at $3,500 per month. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 23, 2017 Category: Pharmaceuticals Source Type: news

CHMP Recommends Skilarence for Psoriasis CHMP Recommends Skilarence for Psoriasis
The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended granting marketing approval for Skilarence for treatment of psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 21, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Valeant Prices Psoriasis Treatment at $3,500 Per Month Valeant Prices Psoriasis Treatment at $3,500 Per Month
Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month, ahead of an expected U.S. launch in the second half of 2017.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Psoriasis Tied to Higher Risk of Uveitis Psoriasis Tied to Higher Risk of Uveitis
People with psoriasis have an increased risk of developing uveitis, according to Taiwan researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Valeant prices psoriasis treatment at $3,500 per month
(Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month, ahead of an expected U.S. launch in the second half of 2017. (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ(TM) (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
LAVAL, Quebec, April 21, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), ... Biopharmaceuticals, Dermatology Valeant Pharmaceuticals, SILIQ, brodalumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 21, 2017 Category: Pharmaceuticals Source Type: news

Risankizumab More Effective in Psoriasis Than Ustekinumab in Early Trial Risankizumab More Effective in Psoriasis Than Ustekinumab in Early Trial
Selective inhibition of IL-23 with risankizumab may be more effective in treating psoriasis than the less specific ustekinumab; more studies are needed to confirm results and assess.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 19, 2017 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Risk of suicidality in people with psoriasis: a systematic review and meta-analysis of cohort studies - Chi CC, Chen TH, Wang SH, Tung TH.
BACKGROUND: Psoriasis has been associated with psychiatric disorders such as depression and anxiety, but its relationship with suicidality (including suicide, suicide attempt, and suicidal ideation) is unclear. OBJECTIVE: Our objective was to asses... (Source: SafetyLit)
Source: SafetyLit - April 17, 2017 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Medical News Today: Injections to treat psoriasis: Types, benefits, and risks
If topical remedies, lifestyle changes, and prescription drugs do not work, a person with psoriasis may want to try injections to help manage symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 17, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis
Review the latest data on the oral immunosuppressant tofacitinib, recently approved for the treatment of rheumatoid arthritis, and currently in Phase III trials for treating chronic plaque psoriasis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Health Tip: Caring for Nail Psoriasis
-- Nail psoriasis causes pitting, discoloration and thickening of the nails. So how to take care of your nails if you have the condition? Here are suggestions from the National Psoriasis Foundation: Trim your nails as short as you can, since longer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2017 Category: Journals (General) Source Type: news

Health Tip: Caring for Nail Psoriasis
Title: Health Tip: Caring for Nail PsoriasisCategory: Health NewsCreated: 4/17/2017 12:00:00 AMLast Editorial Review: 4/17/2017 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 17, 2017 Category: Dermatology Source Type: news

Medical News Today: Psoriasis and pregnancy: Effects, symptoms changes, and treatments
How does pregnancy affect psoriasis? How might symptoms change during pregnancy, will the baby be affected, and what are the suggested treatments? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 15, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriasis scars: Treatment and prevention
How do psoriasis scars form? Do different types of psoriasis lead to different types of scarring, and what treatments are available for psoriasis scars? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 14, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Ayurvedic treatment for psoriasis: Options, remedies, and evidence
Ayurveda is an ancient medical practice. Can it help with the symptoms of psoriasis? What are the risks and safety considerations? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 14, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriasis vs. seborrheic dermatitis: How to tell the difference
In this article, we take a close look at the differences between seborrheic dermatitis and psoriasis. What are the causes? How might they be treated? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 12, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriasis vs. dandruff: How to tell the difference
Learn about dandruff and psoriasis of the scalp. Compare the causes and treatments for both conditions, and understand more about scalp-care. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 12, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Can a gluten-free diet help with psoriasis?
Psoriasis is a chronic skin condition. While there is no cure, a gluten-free diet may help some people better manage their symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 11, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

I’m 33, But My Autoimmune Disease Makes My Body Feel Like I’m 70
As told to Carina Storrs Jennifer Pellegrin, 33, found out she had psoriatic arthritis at a doctor’s visit for an unrelated procedure. At first, she did not think much of the diagnosis or fully understand how it would change her life. But seeing family members cope with the disease opened her eyes to its devastating effects. Now, she finds strength by helping others and credits the autoimmune disease for helping her become the person she is today. At first, being diagnosed with psoriatic arthritis didn’t seem so bad. But that just shows how little I knew about the disease back then. My primary care doctor decid...
Source: Healthy Living - The Huffington Post - April 11, 2017 Category: Consumer Health News Source Type: news

AnaptysBio starts dosing subjects in Phase I trial of ANB019 for inflammatory disorders
US-based biotechnology firm AnaptysBio has started dosing healthy subjects in a Phase I trial of ANB019 for inflammatory disorders such as generalised pustular psoriasis (GPP) and palmo-plantar pustular psoriasis (PPP). (Source: Drug Development Technology)
Source: Drug Development Technology - April 9, 2017 Category: Pharmaceuticals Source Type: news

Medical News Today: Prognosis of psoriatic arthritis: Progression and outlook
In this article, learn how psoriatic arthritis may progress, the quality of life to be expected, and what treatment options are available. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriatic arthritis radiology: Imaging tests for diagnosis
What is psoriatic arthritis and what types of radiology may be used to make a diagnosis? What other tests may be available and who should get checked? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Men More Prone to Severe Psoriasis: Study
Title: Men More Prone to Severe Psoriasis: StudyCategory: Health NewsCreated: 4/6/2017 12:00:00 AMLast Editorial Review: 4/7/2017 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 7, 2017 Category: Dermatology Source Type: news

Men More Prone to Severe Psoriasis: Study
Researchers say this may explain why more males seek treatment for the skin disease (Source: WebMD Health)
Source: WebMD Health - April 6, 2017 Category: Consumer Health News Source Type: news

Men More Prone to Severe Psoriasis: Study
Researchers say this may explain why more males seek treatment for the skin disease (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - April 6, 2017 Category: Reproduction Medicine Tags: Cardiology, Dermatology, Family Medicine, Gynecology, Reproductive Medicine, News, Source Type: news

Men More Prone to Severe Psoriasis
Researchers say this may explain why more males seek treatment for the skin disease Source: HealthDay Related MedlinePlus Pages: Men's Health, Psoriasis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 6, 2017 Category: Consumer Health News Source Type: news

Men More Prone to Severe Psoriasis: Study
THURSDAY, April 6, 2017 -- Severe psoriasis is much more common in men than women, a new study from Sweden reports. Researchers reviewed data from more than 5,400 people in Sweden with the common skin disease. The study found that women had a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 6, 2017 Category: Journals (General) Source Type: news

What Is Psoriasis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 6, 2017 Category: Journals (General) Source Type: news

Medical News Today: Does my baby have psoriasis? Symptoms and treatment
Can babies have psoriasis and what are the different types of psoriasis? What causes psoriasis and what other skin conditions may affect babies? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriatic arthritis: Tests and diagnosis
Learn about psoriatic arthritis, the patterns of psoriatic arthritis, how it is diagnosed, what happens after diagnosis, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriasis in pictures: Different types and symptoms
Psoriasis is a common autoimmune disease that causes changes in the skin. In this article, learn about the different types and how they are managed. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 4, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: XTRAC laser treatment for psoriasis: Uses, benefits, risks
What is psoriasis and what is the XTRAC laser? What are the pros and cons of using the laser and what other phototherapy options are available? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 4, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Pustular Psoriasis
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 4, 2017 Category: Journals (General) Source Type: news

March's top stories: Cancer Research UK's pancreatic cancer trials, Novartis' Cosentyx in psoriasis
Cancer Research UK invested £ 10m in the PRECISION Panc project, including a network of clinical trials for the treatment of pancreatic cancer, and Novartis reported positive results from the extension A2302E1 trial of Cosentyx to modify the course of … (Source: Drug Development Technology)
Source: Drug Development Technology - April 3, 2017 Category: Pharmaceuticals Source Type: news

High prevalence of alcohol use disorders in patients with inflammatory skin diseases - Al-Jefri K, Newbury-Birch D, Muirhead CR, Gilvarry E, Ara újo-Soares V, Reynolds NJ, Kaner E, Hampton PJ.
BACKGROUND: There is a known association between psoriasis and heavy alcohol consumption. Causality remains unclear with evidence supporting both alcohol triggering psoriasis and psoriasis predisposing to heavy alcohol consumption. However, the association... (Source: SafetyLit)
Source: SafetyLit - March 31, 2017 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

New Drug Review 2016 New Drug Review 2016
2016 brought promising new treatments for diabetes, asthma, psoriasis, schizophrenia, and epilepsy. Learn about their profiles in this review.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie ' s Humira (adalimumab) Prescribing Information
NORTH CHICAGO, Ill., March 30, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved the inclusion of moderate to severe fingernail psoriasis data in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 30, 2017 Category: Drugs & Pharmacology Source Type: news

Fingernail Psoriasis Data Added to Humira Prescribing Info Fingernail Psoriasis Data Added to Humira Prescribing Info
The FDA has approved the addition of moderate to severe fingernail psoriasis data to the Humira prescribing information for those with moderate to severe chronic plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 30, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Merck, Avillion ink development deal for nanobody psoriasis treatment
Merck (NYSE:MRK) and Avillion inked a clinical co-development deal today for Merck’s anti IL-17 A/F Nanobody therapy for plaque psoriasis. The financial terms of the deal were not disclosed. The investigational treatment underwent Phase I development and the group plans to initiate Phase II trials this year. According to the terms of the agreement, Avillion is responsible for bringing the nanobody treatment from Phase II to Phase III and financing the clinical program through to regulatory submission. Get the full story at our sister site, Drug Delivery Business News. The post Merck, Avillion ink development deal for n...
Source: Mass Device - March 30, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Wall Street Beat Avillion Merck Source Type: news

U.S. FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie's HUMIRA(R) (adalimumab) Prescribing Information
NORTH CHICAGO, Ill., March 30, 2017 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved the inclusion of moderate to severe fingernail ps... Biopharmaceuticals, FDA AbbVie, HUMIRA, adalimumab, Fingernail Psoriasis, Psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2017 Category: Pharmaceuticals Source Type: news

Merck advances R & D strategy through unique development model with Avillion for Anti IL-17 A/F Nanobody
Merck, a leading science and technology company, today announced a development agreement with Avillion, a UK-based company focused on increasing R&D output through innovative models, for anti IL-17 A/F Nanobody®. Merck's Anti IL-17 A/F Nanobody® is an investigational therapy which has completed Phase I development, and is expected to begin Phase II in plaque psoriasis in 2017. (Source: World Pharma News)
Source: World Pharma News - March 30, 2017 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Psoriasis and Cardiomyopathy: A Review of the Literature Psoriasis and Cardiomyopathy: A Review of the Literature
The incidence of dilated cardiomyopathy is 10 times higher in patients with psoriasis than in the general population. What might be the possible etiology of this association?Southern Medical Journal (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 30, 2017 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Plaque Psoriasis
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 30, 2017 Category: Journals (General) Source Type: news

Guttate Psoriasis
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 29, 2017 Category: Journals (General) Source Type: news